Reset Map

4 Results

ECLA - Estudios Clínicos Latinoamérica

Río de Janeiro, BrasilECLA (Estudios Clínicos Latinoamérica) provides clinical monitoring and trials, pharmacology, and assistance with regulatory, financial, and legal affairs.

Fundacao OsWaldo Cruz (FIOCRUZ)

Av. Brazil, 4365 - Manguinhos, Rio de Janeiro - CEP: 21040-900To promote health and social development, to forge and disseminate scientific and technological knowledge, to be an agent of citizenship. These are the concepts that have guided Fundação Oswaldo Cruz (Oswaldo Cruz Foundation, known as Fiocruz), attached to the Brazilian Ministry of Health and the most prominent science and technology health institution in Latin America. Inaugurated on May 25, 1900 under the name of Federal Serotherapy Institute, Fiocruz was given the mission of fighting the great problems of public health in Brazil. Therefore, Fiocruz became a think tank concerned with the Brazilian reality and experimental medicine. Today the institution is responsible for a range of activities which include research development; highly-regarded hospital and ambulatory care services; production of vaccines, drugs, reagents, and diagnostic kits; education and training of human resources; information and communication in the area of health, science and technology; quality control of products and services, and the implementation of social programs. It has over 11,000 employees and health professionals with different levels of involvement, a workforce proud of being at the service of life.


103 Rua Vaz da Costa Rio de Janeiro, 20760-510 BrazilStructured with the latest technology in equipment and engineering construction, Plast Labor operates in the laboratory market, hospitals and food, beverage, cosmetic and pharmaceutical since 1987. This year, we completed 25 years of production and dedication to the quality of our processes, evolving with the acquisition of knowledge, continued investment in technology and qualified personnel. Today Plast Labor has wide representation in the production of market ready means to use, with more than 500 products in this line. Investments were made for expansion of the existing plant, and further constructed a new unit for industrial manufacturing equipment with innovative ensuring the pioneer in full automation of manufacturing processes of culture media.


Avenida Americo VespucioParexel provides bioequivalence studies as well as clinical services across Phase I to Phase III of drug development including dose escalation, drug-drug interaction, biomarkers, first-in-man studies, ADME, imaging, and clinical research services.